We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

105 hedge funds and large institutions have $68.8M invested in Sanofi Contingent Value Rights in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

2% more funds holding

Funds holding: 103 → 105 (+2)

7% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 15

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

6% less capital invested

Capital invested by funds: $73.1M → $68.8M (-$4.28M)

Holders
105
Holders Change
+2
Holders Change %
+1.94%
% of All Funds
2.27%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
13
Increased
16
Reduced
15
Closed
9
Calls
$15.8M
Puts
–
Net Calls
+$15.8M
Net Calls Change
+$616K

Top Buyers

Rank Fund Capital Flow
1
BHMP
Bardin Hill Management Partners
New York
+$430K
2
SCM
Stonehill Capital Management
New York
+$153K
3
Citadel Advisors
Citadel Advisors
Florida
+$97.1K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$67.2K
5
HCM
Highbridge Capital Management
New York
+$53.2K

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$558K
2
Korea Investment Corp
Korea Investment Corp
South Korea
-$23K
3
CL
CSS LLC
Illinois
-$11.3K
4
US Bancorp
US Bancorp
Minnesota
-$4.67K
5
Ameriprise
Ameriprise
Minnesota
-$3.65K
Name Holding Trade Value Shares
Change 		Change in
Stake
YCM
26
Yakira Capital Management
Connecticut
$70K – – –
UBS Group
27
UBS Group
Switzerland
$31K -$2.2K -4,706 -6%
AL
28
Arnhold LLC
New York
$29K – – –
GI
29
GAMCO Investors
Connecticut
$28K -$233 -500 -0.8%
Royal London Asset Management
30
Royal London Asset Management
United Kingdom
$20K – – –
ZIG
31
Zuckerman Investment Group
Illinois
$19K -$273 -585 -1%
Morgan Stanley
32
Morgan Stanley
New York
$13K -$1.83K -3,929 -12%
TSS
33
Two Sigma Securities
New York
$13K -$799 -1,712 -6%
WVP
34
Worth Venture Partners
New Jersey
$13K +$907 +1,944 +7%
Ameriprise
35
Ameriprise
Minnesota
$12K -$3.65K -7,817 -22%
SDWMA
36
Schneider Downs Wealth Management Advisors
Pennsylvania
$11K – – –
Bank of America
37
Bank of America
North Carolina
$10K +$3.49K +7,474 +58%
Commonwealth Equity Services
38
Commonwealth Equity Services
Massachusetts
$9K -$30 -65 -0.3%
LPL Financial
39
LPL Financial
California
$8K -$116 -249 -1%
WEC
40
Winslow Evans & Crocker
Massachusetts
$8K – – –
CHAM
41
Clear Harbor Asset Management
Connecticut
$7K – – –
MC
42
Moors & Cabot
Massachusetts
$7K – – –
RWP
43
RWA Wealth Partners
Massachusetts
$7K – – –
KC
44
Knuff & Co
California
$7K +$7K +15,000 New
HKAM
45
Horizon Kinetics Asset Management
New York
$7K +$7.44K +15,940 New
FHA
46
Flagship Harbor Advisors
Massachusetts
$6K – – –
BIA
47
Biondo Investment Advisors
Pennsylvania
$6K +$70 +150 +1%
William Blair & Company
48
William Blair & Company
Illinois
$6K +$163 +350 +2%
EAM
49
Erste Asset Management
Austria
$5.4K – – –
RJA
50
Raymond James & Associates
Florida
$5K -$57 -122 -1%
1
2
3 4

GCVRZ Hedge Fund Activity: Q1 2019 in Review

105 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2019, worth a combined $68.8M — down 5.9% from $73.1M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new GCVRZ positions and 9 closed out — a net gain of 4 holders — while 16 added to existing stakes and 15 trimmed.

The largest buyer was Bardin Hill Management Partners, opening a new position worth an estimated $430K. The largest seller was UBS O'Connor, exiting entirely with an estimated $558K sold.

  • 105 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2019, up from 103 in Q4 2018.
  • Funds reported $68.8M of Sanofi Contingent Value Rights stock for Q1 2019, down 5.9% quarter-over-quarter.
  • 13 funds opened new Sanofi Contingent Value Rights positions in Q1 2019 and 9 closed out, a net change of +4 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q1 2019 was Bardin Hill Management Partners, an estimated $430K added.
  • The largest Sanofi Contingent Value Rights seller in Q1 2019 was UBS O'Connor, an estimated $558K sold.

Based on aggregated 13F filings for Q1 2019.